Starna Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $40M

  • Investors
  • 12

Starna Therapeutics General Information

Description

Developer of nucleic acid-based therapeutic formulation designed for targeted delivery applications. The company offers lipid nanoparticle systems, mRNA synthesis, and formulation technologies to support extrahepatic delivery of RNA molecules, serving biotechnology firms and clinical researchers to access precision-targeted treatments for respiratory infections, tumours, and metabolic disorders through scalable preclinical and clinical development pipelines.

Contact Information

Website
www.starnatx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, Building 2, Number 99 Jingu Road, Suzhou Industrial Park
  • Jiangsu Province, People's Republic of China
  • Suzhou, Jiangsu
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Nanotechnology, Life Sciences, Oncology
Corporate Office
  • 2nd Floor, Building 2, Number 99 Jingu Road, Suzhou Industrial Park
  • Jiangsu Province, People's Republic of China
  • Suzhou, Jiangsu
  • China
+86 0512

Starna Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Starna Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC (Series B1) 13-Apr-2026 $40M Completed Generating Revenue
6. Early Stage VC (Series B) 14-Oct-2025 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
4. Early Stage VC 16-Nov-2023 Completed Generating Revenue
3. Secondary Transaction - Private 16-Nov-2023 Completed Generating Revenue
2. Early Stage VC (Series A) 19-Apr-2022 $23.6M $33.6M Completed Generating Revenue
1. Seed Round 12-Dec-2021 $10M $10M Completed Startup
To view Starna Therapeutics’s complete valuation and funding history, request access »

Starna Therapeutics Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Starna Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026143319-A1 In vivo car-t therapy comprising targeting delivery of rna by a novel antibody-conjugated lnp Pending 30-Dec-2024
WO-2024199355-A1 Nucleic acids encoding therapeutic polypeptides and lipid nanoparticle composition comprising the nucleic acids Inactive 29-Mar-2023
US-20260263375-A1 Nucleic acids encoding therapeutic polypeptides and lipid nanoparticle composition comprising the nucleic acids Pending 24-Mar-2023
WO-2024199114-A1 Nucleic acids encoding therapeutic polypeptides and lipid nanoparticle composition comprising the nucleic acids Inactive 24-Mar-2023
WO-2024125469-A1 Novel compounds and use thereof for targeted delivery Inactive 12-Dec-2022 C07C229/16
To view Starna Therapeutics’s complete patent history, request access »

Starna Therapeutics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tencent Investment Corporate Venture Capital Minority
Jifeng Ventures Venture Capital Minority
LAV (Lilly Asia Fund) Corporate Venture Capital Minority
Primavera Capital Group Growth/Expansion Minority
Roche Accelerator Accelerator/Incubator
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Starna Therapeutics FAQs

  • When was Starna Therapeutics founded?

    Starna Therapeutics was founded in 2021.

  • Where is Starna Therapeutics headquartered?

    Starna Therapeutics is headquartered in Suzhou, China.

  • What industry is Starna Therapeutics in?

    Starna Therapeutics’s primary industry is Drug Discovery.

  • Is Starna Therapeutics a private or public company?

    Starna Therapeutics is a Private company.

  • What is Starna Therapeutics’s current revenue?

    The current revenue for Starna Therapeutics is .

  • How much funding has Starna Therapeutics raised over time?

    Starna Therapeutics has raised $116M.

  • Who are Starna Therapeutics’s investors?

    Tencent Investment, Jifeng Ventures, LAV (Lilly Asia Fund), Primavera Capital Group, and Roche Accelerator are 5 of 12 investors who have invested in Starna Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process